HEALTH● LOWJun 27 · Jun 27, 2026, 4:48 AM
Spinal Muscular Atrophy drug: regulatory approval should guide Kerala’s procurement policy, say experts
The Hindu
Kerala cannot continue to procure the original molecule at high prices when an approved generic formulation is available at a fraction of the price, says B. Ekbal
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH23m agoDR Congo: MSF celebrates Ebola patient discharges in Ituri provinceEuroNews [en]HEALTH1h agoCAR tightens border checks tightened as DR Congo's Ebola cases riseAfricanews [en]HEALTH2h agoStoke outlines Q3 2027 EMPEROR readout and plans NDA submission in second half 2027Seeking Alpha TechHEALTH2h agoLiving Through the Heat: Lifestyle changes you must makeVanguard Nigeria